CEO and Potential Co-founder to KTH startup Rizer Biotech AB

Job Description

We want to empower and accelerate drug discovery

Imagine peering into a world where the intricate interplay of large molecules in living cells is clearly detectable. Enabling such observations could lead to the development of enhanced antibiotics, novel treatments for neurodegenerative conditions, and innovative approaches against virus-induced diseases. Rizer Biotech is a KTH spinoff that has developed a new optical measurement technique, published in Nature Biotechnology providing revolutionizing scientific insights for drug discovery and therapeutic research.

We now embark on the next step to commercialize this technology in the multi-billion-dollar drug discovery market. Our technology represents a completely new type of read-out that provides a novel information type to the data-hungry drug-screening pipelines. Using our desktop measurement instruments combined with state-of-the-art data analysis and AI tools, we believe we can accelerate drug development and that our technology can become a valuable asset to pharmaceutical companies around the world.

Accomplishments

Rizer Biotech AB was established in 2023, and as such is still in an early stage of business development. However, the founding team has developed the measurement technology over the last 5 years culminating in a high-impact publication in Nature Biotechnology. Within the last 12 months, the team has also:

• Secured 4.8 MSEK in academic proof-of-concept funding.

• Secured an investment from KTH Holding and initiated contact with other external funding sources.

• Initiated market validation confirming interest from pharma players.

• Filed patents in key covering the essential technological innovation.

• Built the business case with support from KTH Innovation and participated in various programs e.g. in Silicon Valley, fostering valuable connections with potential partners and customers.

Our next CEO

We are seeking an individual with the drive and capability to take the helm of Rizer Biotech and enable us to fully harness the large potential of the technology. As CEO you will build the foundation for the company, and lead business and team development. You will develop and explore potential business models and strategies and your role will be instrumental in shaping the trajectory of Rizer Biotech.

The role will involve a substantial amount of networking and collaboration with external partners and companies. We are looking for a candidate who can help to raise funding, lead the business development, and establish customer agreements and relationships. The challenges ahead will require a leader who can seamlessly blend business acumen with a strong understanding of biotechnology and the drug screening landscape.

What we offer

This position and role at Rizer Biotech offers a unique opportunity to be part of an exciting journey with a true deep-tech company targeting a multi-billion dollar market and the potential to roll out a multinational business. You will be part of a team at the forefront of deep tech in life science, with a strong scientific foundation, networks and a passion for innovation.

We are seeking someone who wants to join the start-up as a co-founder with all the risks and rewards associated with it, as you will get ownership in the company. Still, this is a high-risk / high-reward project and not a role for someone who wants a steady monthly salary or who is looking for a consultancy position for a limited time.

We will offer an initial onboarding period (4-6 months) where you will be hired under a consulting assignment funded by KTH Innovation/KTH Holding to validate the business, devise a commercial roadmap and get some traction. Thereafter, the intention is for you to become a co-founder of the company with incentives for long-term commitment in the form of equity and option programs. You should be committed to dedicating your time to this startup at a significant level (increasing with time and funding situation).